Heart failure, C-CURE, trails involved patients from Belgium, Switzerland and Serbia. Patients in the control group were given standard heart failure treatments and patients in the experimental group were given cardiopietic stem cells along with the standard treatment. Isolated stem cells taken from the patient’s harvested bone marrow were treated with a protein cocktail to replicate the natural process of heart development and injected into the patient’s heart. Researchers developed the protein cocktail by identifying the proteins necessary to help a stem cell become a reparative cell from the hundreds of proteins involved in the heart development process.
Within six months of the stem cell treatment, every patient in the experimental group improved significantly in comparison to the control group patients. The experimental group had a seven percent absolute improvement in ejection fraction (EF) over baseline. Heart pumping function improved, patients also had improved fitness and were able to walk longer distances compared to before treatment. This discovery paves a way for the regenerative medicine solutions.
http://www.sciencedaily.com/releases/2013/04/130410103349.htm
No comments:
Post a Comment